BRAF and thyroid gland carcinoma: To answer this question, we used a FOXE1+/+ and FOXE1+/- BRAFV600E-dependent thyroid cancer mouse model (BRAF) to induce thyroid cancer in the presence of reduced FOXE1 expression [20].